Michail S Lionakis
National Institute of Allergy and Infectious Diseases (NIAID)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Michail S Lionakis as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 02:00 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07202598 · Randomized Stepped Wedge Study of Emapalumab in APECED EnteritisNational Institute of Allergy and Infectious Diseases (NIAID) · recruiting · Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy Enteritis · principal investigator
- Ph2NCT05398809 · Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia AreataNational Institute of Allergy and Infectious Diseases (NIAID) · recruiting · Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced), Alopecia Areata · principal investigator
- N/ANCT04394884 · Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND)National Institute of Allergy and Infectious Diseases (NIAID) · withdrawn · COVID-19 · principal investigator
- N/ANCT03827330 · Retrospective Chart Review of Candida FungemiaNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Candida Fungemia · principal investigator
- N/ANCT01915251 · Study of Antibiotic-induced Vaginal Yeast Infections in Healthy WomenNational Institute of Allergy and Infectious Diseases (NIAID) · terminated · Microbiome, Antibiotic-Induced VVC, Vaginal Candidiasis · principal investigator
- N/ANCT01386437 · Natural History of Individuals With Immune System Problems That Lead to Fungal InfectionsNational Institute of Allergy and Infectious Diseases (NIAID) · recruiting · Chronic Mucocutaneous Candidiasis, Invasive Aspergillosis, CARD9 · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 02:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Immunopathogenesis of Fungal InfectionsZIAAI001175 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · fiscal years 2012 to 2025 · $2,579,234 awarded in 2025Same name and institution; not confirmed by an ID
- NIAID Microbiome ProgramZICAI001233 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · fiscal years 2024 · $2,436,832 awarded in 2024Same name and institution; not confirmed by an ID
- The pathogenesis of COVID-19ZIAAI001318 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · fiscal years 2020 to 2023 · $196,706 awarded in 2023Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 02:00 UTC. The ranking covers the 200 most relevant of 5 PubMed records, and a shared surname and initials can bring in a namesake. All 5 on PubMed
- Therapeutic responses to Roseomonas mucosa in atopic dermatitis may involve lipid-mediated TNF-related epithelial repair.Sci Transl Med · 2020111 citationsRCR 5.8
- SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients.Front Immunol · 202121 citationsRCR 0.9
- Efficacy of Cochleated Amphotericin B in Mouse and Human Mucocutaneous Candidiasis.Antimicrob Agents Chemother · 202221 citationsRCR 2.1
- Ultrarapid Measurement of Diagnostic Antibodies by Magnetic Capture of Immune Complexes.Sci Rep · 20177 citationsRCR 0.4
- Invasive fusariosis masquerading as extramedullary disease in rapidly progressive acute lymphoblastic leukemia.Pediatr Blood Cancer · 20191 citationsRCR 0.0